EMEA Marketing Recommendation May Give European Alli A Boost
This article was originally published in The Tan Sheet
Executive Summary
The European Medicines Agency's support for a marketing authorization for orlistat in Europe signals a key step in GlaxoSmithKline's plan to launch a nonprescription version of the weight-loss drug in that part of the world, the company says
You may also be interested in...
EU Shifts To Centralized OTC Process At Member States’ Expense – GSK Exec
Europe's development of a centralized process for approving nonprescription pharmaceuticals is sapping the resources of the regulatory agencies of European Union member states, a GlaxoSmithKline regulatory executive says
EU Shifts To Centralized OTC Process At Member States’ Expense – GSK Exec
Europe's development of a centralized process for approving nonprescription pharmaceuticals is sapping the resources of the regulatory agencies of European Union member states, a GlaxoSmithKline regulatory executive says
EU Shifts To Centralized OTC Process At Member States’ Expense – GSK Exec
Europe's development of a centralized process for approving nonprescription pharmaceuticals is sapping the resources of the regulatory agencies of European Union member states, a GlaxoSmithKline regulatory executive says